Overall survival between veterans with metastatic castration-resistant prostate cancer treated with enzalutamide or abiraterone with kidney disease.

被引：0
|
作者：
Wilson, Robert
Doherty, Jason M.
Luo, Suhong
Candelieri-Surette, Danielle
Eaton Jr, Daniel B.
Schoen, Martin W.
机构：
[1] St Louis Univ, Sch Med, St Louis, MO USA
[2] St Louis Univ, Dept Hlth & Clin Outcomes Res, St Louis, MO USA
[3] St Louis VA Med Ctr, St Louis, MO USA
[4] Univ Massachusetts Lowell, Lowell, MA USA
[5] VA St Louis Hlth Care Syst, St Louis, MO USA
[6] St Louis Vet Affairs Med Ctr, St Louis, MO USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2025年 / 43卷 / 5_SUPPL期
关键词：
D O I：
10.1200/JCO.2025.43.5_suppl.76
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Cost per median overall survival month for abiraterone acetate and enzalutamide for treatment of patients with metastatic castration-resistant prostate cancer (mCRPC).
    Pilon, Dominic
    Lefebvre, Patrick
    Queener, Marykay
    Ellis, Lorie
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [32] Serum testosterone level and overall survival in first-line abiraterone and enzalutamide for metastatic castration-resistant prostate cancer patients.
    Silveira Vilbert, Maysa Tamara
    Cesca, Marcelle Goldner
    Pandolfi, Natasha Carvalho
    Calsavara, Vinicius Fernando
    de Mendonca Uchoa, Bruno Cezar
    de Andrade, Poliana
    Coelho, Ricardo Lima
    Corassa, Marcelo
    Rinck, Jose A.
    Dettino, Aldo A.
    Oliveira, Thiago Bueno
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [33] Metastatic castration-resistant prostate cancer: targeting the mechanisms of resistance to abiraterone acetate and enzalutamide
    Modena, Alessandra
    Ciccarese, Chiara
    Fantinel, Emanuela
    Bimbatti, Davide
    Tortora, Giampaolo
    Massari, Francesco
    EXPERT REVIEW OF ANTICANCER THERAPY, 2015, 15 (09) : 1037 - 1048
  • [34] Enzalutamide versus abiraterone acetate for the treatment of men with metastatic castration-resistant prostate cancer
    Zhang, Tian
    Zhu, Jason
    George, Daniel J.
    Armstrong, Andrew J.
    EXPERT OPINION ON PHARMACOTHERAPY, 2015, 16 (04) : 473 - 485
  • [35] COST PER MEDIAN OVERALL SURVIVAL ASSOCIATED WITH ABIRATERONE ACETATE AND ENZALUTAMIDE FOR TREATMENT OF PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER IN COLOMBIA
    Aguirre, A.
    Guerrero, E.
    VALUE IN HEALTH, 2017, 20 (09) : A876 - A877
  • [36] Optimal sequencing of enzalutamide and abiraterone in men with metastatic castration-resistant prostate cancer (mCRPC)
    Maughan, Benjamin Louis
    Suzman, Daniel L.
    Nadal, Rosa Maria
    Bassi, Sunakshi
    Antonarakis, Emmanuel S.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [37] Comparative Effectiveness of Abiraterone and Enzalutamide in Patients With Metastatic Castration-Resistant Prostate Cancer in Taiwan
    Li, Pei-Yu
    Lu, Ying-Hao
    Chen, Chung-Yu
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [38] Medication patterns of abiraterone acetate plus prednisone or enzalutamide and PSA progression in veterans with metastatic castration-resistant prostate cancer
    Freedland, Stephen J.
    Li, Sophia
    Pilon, Dominic
    Bhak, Rachel H.
    Narkhede, Sahil
    Lefebvre, Patrick
    Young-Xu, Yinong
    CURRENT MEDICAL RESEARCH AND OPINION, 2021, 37 (04) : 635 - 642
  • [39] Early PSA progression in abiraterone/enzalutamide-treated patients with metastatic castration-resistant prostate cancer.
    Lopez-Campos, Fernando
    Gomez-Iturriaga, Alfonso
    Llacer Perez, Casilda
    Henriquez, Ivan
    Peleteiro, Paula
    Lozano, Rebeca
    Castano, Ana
    Romero-Laorden, Nuria
    Molina-Cerrillo, Javier
    Alvarez-Rodriguez, Sara
    Piquer, Teresa
    Navarro-Castellon, Joaquin
    Jose Conde-Moreno, Antonio
    Ramirez-Backhaus, Miguel
    Barrionuevo, Patricia
    Garcia, Raquel
    de los Llanos Perez-Haro, Maria
    Castro, Elena
    Olmos, David
    Lorente, David
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [40] Statin Use and Survival in Patients with Metastatic Castration-resistant Prostate Cancer Treated with Abiraterone Acetate
    Di Lorenzo, Giuseppe
    Sonpavde, Guru
    Pond, Gregory
    Lucarelli, Giuseppe
    Rossetti, Sabrina
    Facchini, Gaetano
    Scagliarini, Sarah
    Carteni, Giacomo
    Federico, Piera
    Daniele, Bruno
    Morelli, Franco
    Bellelli, Teresa
    Ferro, Matteo
    De Placido, Sabino
    Buonerba, Carlo
    EUROPEAN UROLOGY FOCUS, 2018, 4 (06): : 874 - 879
12345